The continuous emergence of SARS-CoV-2 variants highlights the need of developing
vaccines with broad protection. Here, according to the immune-escape capability and …

Large-scale populations in the world have been vaccinated with COVID-19 vaccines, however,
breakthrough infections of SARS-CoV-2 are still growing rapidly due to the emergence of …

Inducing durable and effective immunity against severe acute respiratory syndrome
Coronavirus 2 (SARS-CoV-2) via vaccination is essential to combat the current pandemic of …

Respiratory syncytial virus (RSV) is one of the most important pathogens causing respiratory
tract infection in humans, especially in infants and the elderly. The identification and …

Rationale: Respiratory syncytial virus (RSV) is the leading cause of childhood respiratory
infections worldwide; however, no vaccine is available, and treatment options are limited. …

An ongoing randomized, double-blind, controlled phase 2 trial was conducted to evaluate the
safety and immunogenicity of a mosaic-type recombinant vaccine candidate, named NVSI-…

Human norovirus (HuNoV) is the main cause of acute non-bacterial gastroenteritis worldwide.
There is no vaccine currently available to prevent HuNoV infection. HuNoV is a highly …

The spike (S) protein receptor-binding domain (RBD) of SARS-CoV-2 is an attractive target
for COVID-19 vaccine developments, which naturally exists in a trimeric form. Here, guided …

We propose an efficient integration of SWATH with MRM for biomarker discovery and verification
when the corresponding ion library is well established. We strictly controlled the false …

BACKGROUND The rising breakthrough infections caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) variants, especially Omicron and its sub-lineages, have …